ICONplc is a global provider of outsourced drug development services and offers a flexible partnership model for biotechs, acting as a fully externalised project development team. We offer a full range of clinical, consulting and commercial services.
ICON can assist biotechs in establishing key clinical development processes and infrastructure internally, including:
Due diligence and asset valuation processes
Asset development consulting
Quality management systems and standard operating procedures
Medical safety boards